Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NASH Therapeutic Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Vitamin E and Pioglitazone
1.2.3 Ocaliva
1.2.4 Elafibranor
1.2.5 Selonsertib and Cenicriviroc
1.3 Market by Application
1.3.1 Global NASH Therapeutic Drugs Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacy
1.3.3 Online Provider
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global NASH Therapeutic Drugs Market Perspective (2018-2033)
2.2 NASH Therapeutic Drugs Growth Trends by Region
2.2.1 Global NASH Therapeutic Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 NASH Therapeutic Drugs Historic Market Size by Region (2018-2023)
2.2.3 NASH Therapeutic Drugs Forecasted Market Size by Region (2024-2033)
2.3 NASH Therapeutic Drugs Market Dynamics
2.3.1 NASH Therapeutic Drugs Industry Trends
2.3.2 NASH Therapeutic Drugs Market Drivers
2.3.3 NASH Therapeutic Drugs Market Challenges
2.3.4 NASH Therapeutic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NASH Therapeutic Drugs Players by Revenue
3.1.1 Global Top NASH Therapeutic Drugs Players by Revenue (2018-2023)
3.1.2 Global NASH Therapeutic Drugs Revenue Market Share by Players (2018-2023)
3.2 Global NASH Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NASH Therapeutic Drugs Revenue
3.4 Global NASH Therapeutic Drugs Market Concentration Ratio
3.4.1 Global NASH Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NASH Therapeutic Drugs Revenue in 2022
3.5 NASH Therapeutic Drugs Key Players Head office and Area Served
3.6 Key Players NASH Therapeutic Drugs Product Solution and Service
3.7 Date of Enter into NASH Therapeutic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NASH Therapeutic Drugs Breakdown Data by Type
4.1 Global NASH Therapeutic Drugs Historic Market Size by Type (2018-2023)
4.2 Global NASH Therapeutic Drugs Forecasted Market Size by Type (2024-2033)
5 NASH Therapeutic Drugs Breakdown Data by Application
5.1 Global NASH Therapeutic Drugs Historic Market Size by Application (2018-2023)
5.2 Global NASH Therapeutic Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America NASH Therapeutic Drugs Market Size (2018-2033)
6.2 North America NASH Therapeutic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America NASH Therapeutic Drugs Market Size by Country (2018-2023)
6.4 North America NASH Therapeutic Drugs Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NASH Therapeutic Drugs Market Size (2018-2033)
7.2 Europe NASH Therapeutic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe NASH Therapeutic Drugs Market Size by Country (2018-2023)
7.4 Europe NASH Therapeutic Drugs Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NASH Therapeutic Drugs Market Size (2018-2033)
8.2 Asia-Pacific NASH Therapeutic Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NASH Therapeutic Drugs Market Size (2018-2033)
9.2 Latin America NASH Therapeutic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America NASH Therapeutic Drugs Market Size by Country (2018-2023)
9.4 Latin America NASH Therapeutic Drugs Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NASH Therapeutic Drugs Market Size (2018-2033)
10.2 Middle East & Africa NASH Therapeutic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan Plc (Tobira)
11.1.1 Allergan Plc (Tobira) Company Detail
11.1.2 Allergan Plc (Tobira) Business Overview
11.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Introduction
11.1.4 Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2018-2023)
11.1.5 Allergan Plc (Tobira) Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Detail
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb NASH Therapeutic Drugs Introduction
11.2.4 Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2018-2023)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Galmed Pharmaceuticals
11.3.1 Galmed Pharmaceuticals Company Detail
11.3.2 Galmed Pharmaceuticals Business Overview
11.3.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Introduction
11.3.4 Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2018-2023)
11.3.5 Galmed Pharmaceuticals Recent Development
11.4 Genfit SA
11.4.1 Genfit SA Company Detail
11.4.2 Genfit SA Business Overview
11.4.3 Genfit SA NASH Therapeutic Drugs Introduction
11.4.4 Genfit SA Revenue in NASH Therapeutic Drugs Business (2018-2023)
11.4.5 Genfit SA Recent Development
11.5 Gilead Sciences, Inc.
11.5.1 Gilead Sciences, Inc. Company Detail
11.5.2 Gilead Sciences, Inc. Business Overview
11.5.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Introduction
11.5.4 Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2018-2023)
11.5.5 Gilead Sciences, Inc. Recent Development
11.6 Intercept Pharmaceuticals, Inc.
11.6.1 Intercept Pharmaceuticals, Inc. Company Detail
11.6.2 Intercept Pharmaceuticals, Inc. Business Overview
11.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Introduction
11.6.4 Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2018-2023)
11.6.5 Intercept Pharmaceuticals, Inc. Recent Development
11.7 Zydus Cadila
11.7.1 Zydus Cadila Company Detail
11.7.2 Zydus Cadila Business Overview
11.7.3 Zydus Cadila NASH Therapeutic Drugs Introduction
11.7.4 Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2018-2023)
11.7.5 Zydus Cadila Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global NASH Therapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Vitamin E and Pioglitazone
Table 3. Key Players of Ocaliva
Table 4. Key Players of Elafibranor
Table 5. Key Players of Selonsertib and Cenicriviroc
Table 6. Global NASH Therapeutic Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global NASH Therapeutic Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global NASH Therapeutic Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global NASH Therapeutic Drugs Market Share by Region (2018-2023)
Table 10. Global NASH Therapeutic Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global NASH Therapeutic Drugs Market Share by Region (2024-2033)
Table 12. NASH Therapeutic Drugs Market Trends
Table 13. NASH Therapeutic Drugs Market Drivers
Table 14. NASH Therapeutic Drugs Market Challenges
Table 15. NASH Therapeutic Drugs Market Restraints
Table 16. Global NASH Therapeutic Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global NASH Therapeutic Drugs Market Share by Players (2018-2023)
Table 18. Global Top NASH Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NASH Therapeutic Drugs as of 2022)
Table 19. Ranking of Global Top NASH Therapeutic Drugs Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by NASH Therapeutic Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players NASH Therapeutic Drugs Product Solution and Service
Table 23. Date of Enter into NASH Therapeutic Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global NASH Therapeutic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global NASH Therapeutic Drugs Revenue Market Share by Type (2018-2023)
Table 27. Global NASH Therapeutic Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global NASH Therapeutic Drugs Revenue Market Share by Type (2024-2033)
Table 29. Global NASH Therapeutic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global NASH Therapeutic Drugs Revenue Market Share by Application (2018-2023)
Table 31. Global NASH Therapeutic Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global NASH Therapeutic Drugs Revenue Market Share by Application (2024-2033)
Table 33. North America NASH Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America NASH Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America NASH Therapeutic Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe NASH Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe NASH Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe NASH Therapeutic Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific NASH Therapeutic Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America NASH Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America NASH Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America NASH Therapeutic Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa NASH Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 48. Allergan Plc (Tobira) Company Detail
Table 49. Allergan Plc (Tobira) Business Overview
Table 50. Allergan Plc (Tobira) NASH Therapeutic Drugs Product
Table 51. Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 52. Allergan Plc (Tobira) Recent Development
Table 53. Bristol Myers Squibb Company Detail
Table 54. Bristol Myers Squibb Business Overview
Table 55. Bristol Myers Squibb NASH Therapeutic Drugs Product
Table 56. Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 57. Bristol Myers Squibb Recent Development
Table 58. Galmed Pharmaceuticals Company Detail
Table 59. Galmed Pharmaceuticals Business Overview
Table 60. Galmed Pharmaceuticals NASH Therapeutic Drugs Product
Table 61. Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 62. Galmed Pharmaceuticals Recent Development
Table 63. Genfit SA Company Detail
Table 64. Genfit SA Business Overview
Table 65. Genfit SA NASH Therapeutic Drugs Product
Table 66. Genfit SA Revenue in NASH Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 67. Genfit SA Recent Development
Table 68. Gilead Sciences, Inc. Company Detail
Table 69. Gilead Sciences, Inc. Business Overview
Table 70. Gilead Sciences, Inc. NASH Therapeutic Drugs Product
Table 71. Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 72. Gilead Sciences, Inc. Recent Development
Table 73. Intercept Pharmaceuticals, Inc. Company Detail
Table 74. Intercept Pharmaceuticals, Inc. Business Overview
Table 75. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product
Table 76. Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 77. Intercept Pharmaceuticals, Inc. Recent Development
Table 78. Zydus Cadila Company Detail
Table 79. Zydus Cadila Business Overview
Table 80. Zydus Cadila NASH Therapeutic Drugs Product
Table 81. Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 82. Zydus Cadila Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NASH Therapeutic Drugs Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global NASH Therapeutic Drugs Market Share by Type: 2022 VS 2033
Figure 3. Vitamin E and Pioglitazone Features
Figure 4. Ocaliva Features
Figure 5. Elafibranor Features
Figure 6. Selonsertib and Cenicriviroc Features
Figure 7. Global NASH Therapeutic Drugs Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global NASH Therapeutic Drugs Market Share by Application: 2022 VS 2033
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Online Provider Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. NASH Therapeutic Drugs Report Years Considered
Figure 13. Global NASH Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global NASH Therapeutic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global NASH Therapeutic Drugs Market Share by Region: 2022 VS 2033
Figure 16. Global NASH Therapeutic Drugs Market Share by Players in 2022
Figure 17. Global Top NASH Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NASH Therapeutic Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by NASH Therapeutic Drugs Revenue in 2022
Figure 19. North America NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America NASH Therapeutic Drugs Market Share by Country (2018-2033)
Figure 21. United States NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe NASH Therapeutic Drugs Market Share by Country (2018-2033)
Figure 25. Germany NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific NASH Therapeutic Drugs Market Share by Region (2018-2033)
Figure 33. China NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America NASH Therapeutic Drugs Market Share by Country (2018-2033)
Figure 41. Mexico NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa NASH Therapeutic Drugs Market Share by Country (2018-2033)
Figure 45. Turkey NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia NASH Therapeutic Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Allergan Plc (Tobira) Revenue Growth Rate in NASH Therapeutic Drugs Business (2018-2023)
Figure 48. Bristol Myers Squibb Revenue Growth Rate in NASH Therapeutic Drugs Business (2018-2023)
Figure 49. Galmed Pharmaceuticals Revenue Growth Rate in NASH Therapeutic Drugs Business (2018-2023)
Figure 50. Genfit SA Revenue Growth Rate in NASH Therapeutic Drugs Business (2018-2023)
Figure 51. Gilead Sciences, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2018-2023)
Figure 52. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2018-2023)
Figure 53. Zydus Cadila Revenue Growth Rate in NASH Therapeutic Drugs Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed